Octopus Leads TrialReach Funding
Octopus has led a 2 million pound ($3.1 million) investment round into TrialReach, an online platform that is transforming clinical trials by connecting patients with healthcare companies and research organisations to make new treatments available more quickly and efficiently. Octopus is investing alongside existing investors Amadeus Capital Partners, which first invested in TrialReach in 2011.
8 May 2013•5 mins read
